Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/37013
Title: mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?
Authors: Wijtvliet, Veerle P. W. M.
Arien, Kevin K.
ABRAMS, Steven 
Couttenye, Marie M.
Mestrez, Fabienne
Marien , Joachim
De Winter, Benedicte Y.
Van Damme , Pierre
Pipeleers, Lissa
Wissing, Karl Martin
Abramowicz, Daniel
Ledeganck, Kristien J.
Issue Date: 2022
Publisher: OXFORD UNIV PRESS
Source: Nephrology, dialysis, transplantation, 37 (4) , p. 799-803
Notes: Wijtvliet, VPWM (corresponding author), Univ Antwerp, Lab Expt Med & Pediat, Antwerp, Belgium.; Wijtvliet, VPWM (corresponding author), Univ Antwerp, Infla Med Ctr Excellence, Antwerp, Belgium.; Wijtvliet, VPWM (corresponding author), Antwerp Univ Hosp, Dept Nephrol & Hypertens, Edegem, Belgium.
veerle.wijtvliet@uantwerpen.be
Keywords: Antibodies, Viral;BNT162 Vaccine;COVID-19 Vaccines;Humans;Renal Dialysis;Transplant Recipients;2019-nCoV Vaccine mRNA-1273;Kidney Transplantation
Document URI: http://hdl.handle.net/1942/37013
ISSN: 0931-0509
e-ISSN: 1460-2385
DOI: 10.1093/ndt/gfab352
ISI #: WOS:000764777200001
Rights: The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
Category: A1
Type: Journal Contribution
Validations: ecoom 2023
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
gfab352.pdfPublished version223.9 kBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

16
checked on Oct 11, 2025

WEB OF SCIENCETM
Citations

12
checked on Oct 17, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.